(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from USPTO

ZOLGENSMA

Did you know this trademark is already registered in United States?

Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.

Active USPTO registrationType: WordOffice: US

Quick snapshot

ZOLGENSMA

ST13

US500000087673650

Class

5

Filing

87673650

Registration

5897769

Risk and opportunity diagnosis

Executive reading for naming, filing, and monitoring decisions.

Attention: there is active risk

USPTO status

Active USPTO registration

Case type

Application and registration

Recorded events

53

Latest update

06/04/2025

Classification

Registered

Trademark type

Word

Nice classes

5

Filing date

11/06/2017

Registration date

10/29/2019

Expiration date

-

Recommended action

Perform a full collision analysis and validate classes before any filing or trademark investment.

Next step

These are the details of the registration process. Even so, constant monitoring is what ensures peace of mind that your main asset remains protected.

Complete case details

Structured fields from the responsible authority and the official record.

Status date

06/03/2025

Last transaction

06/04/2025

Responsible office

United States Patent and Trademark Office

Status code

702

Official register

Principal Register

Filing basis

Intent to use

First use anywhere

06/10/2019

First use in commerce

06/10/2019

Drawing code

4

Owner type

25

Owner location

BASEL, CH

Examiner

MORRIS, KRISTINA

Current location

Historical data usage

Holders and representatives

Holders

NOVARTIS AG
AveXis, Inc.

Representatives

Maury M. Tepper, III Tepper & Eyster, PLLC

Technical classification

Nice Classes

Class 5

Vienna Codes

No Vienna codes available.

Goods and services

Class 5

Pharmaceutical preparations and gene therapy products in the nature of injectable biologic preparations for geneticneurologicalmotor neuronneuromuscular diseasesdisorders and conditions; pharmaceutical preparations and gene therapy products in the nature of biological preparations containing genetic materials for treating spinal muscular atrophyloss of motor neuronsmuscle degenerationmuscle weaknessparalysis; gene therapy preparation in the nature of biological preparations containing genetic materials for sustained survival motor neuron protein expression

Publications

History of USPTO decisions and trademark events.

53 publications found

NA85

NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED

06/03/2025

C15A

REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.

06/03/2025

APRE

CASE ASSIGNED TO POST REGISTRATION PARALEGAL

06/03/2025

E815

TEAS SECTION 8 & 15 RECEIVED

02/10/2025

REM1

COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED

10/29/2024

CORV

REVIEW OF CORRESPONDENCE COMPLETE - ADDRESS UPDATED

07/06/2020

CHAN

APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED

07/03/2020

TCCA

TEAS CHANGE OF CORRESPONDENCE RECEIVED

07/03/2020

ECDR

TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS

07/03/2020

ARAA

ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

07/03/2020

REAP

TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

07/03/2020

COAR

TEAS CHANGE OF OWNER ADDRESS RECEIVED

07/03/2020

ASGN

AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP

07/01/2020

R.PR

REGISTERED-PRINCIPAL REGISTER

10/29/2019

SUNA

NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED

09/26/2019

CNPR

ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED

09/25/2019

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

09/25/2019

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

09/25/2019

TROA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

09/20/2019

ARAA

ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

09/12/2019

REAP

TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

09/12/2019

DMCC

DATA MODIFICATION COMPLETED

08/16/2019

ALIE

ASSIGNED TO LIE

08/14/2019

EWAF

TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS

08/05/2019

GNRN

NOTIFICATION OF NON-FINAL ACTION E-MAILED

07/19/2019

GNRT

NON-FINAL ACTION E-MAILED

07/19/2019

CNRT

SU - NON-FINAL ACTION - WRITTEN

07/19/2019

EXRA

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

06/29/2019

SUPC

STATEMENT OF USE PROCESSING COMPLETE

06/28/2019

EX2G

SOU EXTENSION 2 GRANTED

06/28/2019

AITU

CASE ASSIGNED TO INTENT TO USE PARALEGAL

06/28/2019

IUAF

USE AMENDMENT FILED

06/25/2019

EXT2

SOU EXTENSION 2 FILED

06/25/2019

EEXT

SOU TEAS EXTENSION RECEIVED

06/25/2019

EISU

TEAS STATEMENT OF USE RECEIVED

06/25/2019

EXRA

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

01/11/2019

EX1G

SOU EXTENSION 1 GRANTED

01/09/2019

EXT1

SOU EXTENSION 1 FILED

01/09/2019

EEXT

SOU TEAS EXTENSION RECEIVED

01/09/2019

NOAM

NOA E-MAILED - SOU REQUIRED FROM APPLICANT

07/10/2018

NPUB

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

05/15/2018

PUBO

PUBLISHED FOR OPPOSITION

05/15/2018

NONP

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

04/25/2018

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

04/07/2018

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

03/30/2018

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

03/30/2018

TROA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

03/30/2018

GNRN

NOTIFICATION OF NON-FINAL ACTION E-MAILED

02/23/2018

GNRT

NON-FINAL ACTION E-MAILED

02/23/2018

CNRT

NON-FINAL ACTION WRITTEN

02/23/2018

DOCK

ASSIGNED TO EXAMINER

02/16/2018

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

11/16/2017

NWAP

NEW APPLICATION ENTERED

11/09/2017

Continuous trademark protection

Get notified about every new filing that threatens ZOLGENSMA or your mark.

Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.